Capsida Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|
| CAP-002 | STXBP1-Developmental and Epileptic Encephalopathy (STXBP1-DEE) | Phase 1 |
| CAP-003 | Parkinson's Disease Associated with GBA Mutations (PD-GBA) | Preclinical/IND-enabling |
| CAP-004 | Friedreich's Ataxia (FA) | IND-enabling |